Since 2016 through its 1787 law, Colombia has regulated access to medical cannabis, and it would seem that the country has everything to be one of the key players in the region.
However, in spite of recent regulations in favor of the progress of the industry, there still seems to be resistance when it comes to the full development of the same. In a recent interview with W radio station, Fidel Moreno director of the magazine Cáñamo en Colombia y España (Hemp in Colombia and Spain) assured that there is still a problem of prejudice and conflicting economic interests that have prevented the industry from advancing. He added “Colombia is the only country with regulated medical cannabis that prevents the marketing of the flower (…) Colombia cannot afford to lose the opportunity to be at the forefront of what is the production of medical cannabis”.
The aforementioned, paired with a complex international tax reality can hurt Colombia’s opportunity to become a main exporter in the region. Even though the country began on the right foot with an excellent regulatory frame, it is quickly falling behind with the world’s progress, not to mention the recent changes in the United Nations that have set the tone of the global progress of the market.
Colombia will have to soon enough set aside these delays and get in sync with the rest of the world, meaning it will have to solve the bottleneck of the quotas, the export barriers, patient access and improve its control measures.
Nonetheless, as expressed in passed blogs, if the country manages to successfully do this, it will soon be a major exporter in the region and the world.